UK Spatial Genomics & Transcriptomics Market Size & Outlook
UK spatial genomics & transcriptomics market, 2018-2030 (US$M)
Related Markets
UK spatial genomics & transcriptomics market highlights
- The UK spatial genomics & transcriptomics market generated a revenue of USD 26.1 million in 2023 and is expected to reach USD 57.8 million by 2030.
- The UK market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Spatial genomics & transcriptomics market data book summary
| Market revenue in 2023 | USD 26.1 million |
| Market revenue in 2030 | USD 57.8 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Software |
| Key market players worldwide | Natera Inc, 10x Genomics Inc Ordinary Shares - Class A, Dovetail Genomics, Illumina Inc, NanoString Technologies, Seven Bridges, Horizon Discovery, Bio-Techne Corp, S2 Genomics |
Other key industry trends
- In terms of revenue, UK accounted for 8.4% of the global spatial genomics & transcriptomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK spatial genomics & transcriptomics market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 57.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Spatial Genomics & Transcriptomics Market Scope
Spatial Genomics & Transcriptomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK spatial genomics & transcriptomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to spatial genomics & transcriptomics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 52.87% in 2023. Horizon Databook has segmented the UK spatial genomics & transcriptomics market based on instruments, consumables, software covering the revenue growth of each sub-segment from 2018 to 2030.
The UK was one of the few European countries to launch a whole genome sequencing program. Genomics England aims at sequencing nearly 100,000 whole genomes from patients suffering from rare diseases & cancer from 11 Genomic Medicine Centres.
The project is undertaken by majority of biotech and pharma players and nearly 10 of them have signed the GENE Consortium in order to access 5,000 sequenced genomes. Some of the companies in this consortium include Roche, AstraZeneca, and GSK.
In October 2018, this project was expanded with an aim to sequence 5 million genomes over the next 5 years. Similarly, the UK is home to several academic institutions that are currently working on development of novel techniques for single cell genomics.
Reasons to subscribe to UK spatial genomics & transcriptomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK spatial genomics & transcriptomics market databook
-
Our clientele includes a mix of spatial genomics & transcriptomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK spatial genomics & transcriptomics market , including forecasts for subscribers. This country databook contains high-level insights into UK spatial genomics & transcriptomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK spatial genomics & transcriptomics market size, by product, 2018-2030 (US$M)
UK Spatial Genomics & Transcriptomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
